AM-0216

Amgen 16 (Amgen16) is a highly potent inhibitor of NF-κB inducing Kinase (NIK) with Ki of 2 nM, selectively decrease viability of MMCLs in which NFkB activity is NIK-dependent; IKKβ inhibitor MLX and dexamethasone enhances cytotoxicity of NIK-inhibitors in MMCLs with NIK-dependent NFkB activation, blocks BAFF induced NFkB activation in myeloma cells combined with IKKβ inhibitors.

References 1. Demchenko YN, et al. Oncotarget. 2014 Jun 30;5(12):4554-66. 2. Henry KL, et al. Sci Signal. 2018 Jul 31;11(541). pii: eaam8216. View Related Products by Target NF-κB inducing Kinase (NIK)